Assembly Biosciences (ASMB) Capital Expenditures (QoQ) (2011 - 2026)
Assembly Biosciences (ASMB) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-20.83% |
| Dec 31, 2025 |
-42.86% |
| Jun 30, 2024 |
0.00% |
| Mar 31, 2024 |
-80.28% |
| Dec 31, 2023 |
-47.79% |
| Sep 30, 2023 |
183.33% |
| Jun 30, 2020 |
523.08% |
| Mar 31, 2020 |
333.33% |
| Jun 30, 2019 |
-96.57% |
| Mar 31, 2019 |
605.21% |
| Dec 31, 2018 |
470.27% |
| Sep 30, 2018 |
-30.19% |
| Jun 30, 2018 |
35.90% |
| Mar 31, 2018 |
-89.22% |
| Dec 31, 2017 |
-28.07% |
| Dec 31, 2016 |
239.82% |
| Mar 31, 2016 |
-78.94% |
| Jun 30, 2015 |
-43.73% |
| Mar 31, 2015 |
-76.27% |
| Dec 31, 2014 |
621.62% |
